Key result
Existing models predict 30-day TAVI mortality poorly with a top AU-ROC of 0.64.
Why the study?
Little is known about the predictive performance of existing early mortality prediction models in external TAVI populations.
Do existing mortality prediction models accurately predict 30-day mortality in patients undergoing TAVI?
Observational (n=6,177)
Yes
Do existing mortality prediction models accurately predict 30-day mortality in patients undergoing TAVI?
Existing mortality prediction models for TAVI have poor predictive performance in a Dutch cohort, highlighting the need for updated or locally developed models.
Answers are grounded in this paper and cite their sources.
Existing models warrant caution for 30-day TAVI mortality risk stratification; leaves open the need for updated or locally derived tools.
BACKGROUND: Several mortality prediction models (MPM) are used for predicting early (30-day) mortality following transcatheter aortic valve implantation (TAVI). Little is known about their predictive performance in external TAVI populations. We aim to externally validate established MPMs on a large TAVI dataset from the Netherlands Heart Registration (NHR). METHODS: We included data from NHR-patients who underwent TAVI during 2013-2017. We calculated the predicted mortalities per MPM. We assessed the predictive performance by discrimination (Area Under Receiver Operating-characteristic Curve, AU-ROC); the Area Under Precision-Recall Curve, AU-PRC; calibration (using calibration-intercept and calibration-slope); Brier Score and Brier Skill Score. We also assessed the predictive performance among subgroups: tertiles of mortality-risk for non-survivors, gender, and access-route. RESULTS: We included 6177 TAVI-patients with an observed early-mortality rate of 4.5% (n = 280). We applied seven MPMs (STS, EuroSCORE-I, EuroSCORE-II, ACC-TAVI, FRANCE-2, OBSERVANT, and German-AV) on our cohort. The highest AU-ROCs were 0.64 (95%CI 0.61-0.67) for ACC-TAVI and 0.63 (95%CI 0.60-0.67) for FRANCE-2. All MPMs had a very low AU-PRC of ≤0.09. ACC-TAVI had the best calibration-intercept and calibration-slope. Brier Score values ranged between 0.043 and 0.063. Brier Skill Score ranged between -0.47 and 0.004. ACC-TAVI and FRANCE-2 predicted high mortality-risk better than other MPMs. ACC-TAVI outperformed other MPMs in different subgroups. CONCLUSION: The ACC-TAVI model has relatively the best predictive performance. However, all models have poor predictive performance. Because of the poor discrimination, miscalibration and limited accuracy of the models there is a need to update the existing models or develop new TAVI-specific models for local populations.
No takes yet. Share an insight, caveat, or question.
Al‐Farra et al. (2020) conducted an observational in Transcatheter Aortic Valve Implantation (TAVI) (n=6,177). Mortality prediction models (STS, EuroSCORE-I, EuroSCORE-II, ACC-TAVI, FRANCE-2, OBSERVANT, German-AV) was evaluated on Predictive performance for early (30-day) mortality (AU-ROC 0.64, 95% CI 0.61-0.67). Existing mortality prediction models for 30-day mortality after TAVI demonstrated poor predictive performance, with the best-performing model (ACC-TAVI) achieving an AU-ROC of 0.64 (95% CI 0.61-0.67).
Synapse has enriched 10 related papers. Consider them for comparative context: